机译:Use of BTK inhibitors with special focus on ibrutinib in Waldenstr?m macroglobulinemia: An expert panel opinion statement
Department of Molecular Biotechnologies and Health Sciences,University of Torino;
UOC Ematologia AO Cosenza;
Hematology,Università Cattolica del Sacro CuoreHematology,Sapienza UniversityDepartment of Medicine,University of PerugiaDepartment of Medicine, Section of Hematology,University of VeronaIRCCS Azienda Ospedaliero‐Universitaria di Bologna,Diagnostica e Sperimentale Università degli StudiHematology,Niguarda Cancer CenterDivision of Hematology,Fondazione IRCCS Policlinico San Matteo;
BTK inhibitors; ibrutinib; real‐world; recommendations; Waldenstr?m macroglobulinemia;